Merck logo
默克药厂
Medical Director, Global Clinical Development Oncology

Medical Director, Global Clinical Development Oncology

发布于 2 小时前

中层管理(经理/总监)

AI 估算 · 14.5–21.8万 · AI 参考估算
Billerica, Massachusetts, United States
高级经验
学历未注明
全职员工混合式弹性办公临床研究
临床研究
Ema
Fda
Health Authority Interactions
Ich-Gcp
Phase I-Iii

值不值得投

80综合评分

综合评分 80

Global oncology medical leadership role with strong scientific impact, disclosed competitive pay, hybrid work, and meaningful patient mission

从薪资福利、成长发展、工作生活和使命价值四个维度综合评估,方便横向比较。

薪资怎么样

18.2万

比临床研究中位数高

发布情况

新岗位 · 今天发布

市场机会

选择面较广

临床研究 · 约 890 个在招

职位详情

关于这个职位

该职位负责全球肿瘤临床开发项目的医学与科学领导,覆盖一期至三期研究、注册申报及监管机构沟通

你将整合临床、转化医学和生物标志物数据,推动适应症、剂量和患者选择等关键开发决策

最低要求

最低任职要求:

MD with expertise in clinical drug development
Required expertise in Oncology
Minimum 3 years of industry experience in clinical R&D; within pharma/biotech
Experience supporting or leading clinical studies across Phase 1 through Phase III
Experience contributing to clinical development strategy, regulatory submissions, and registration-enabling activities
Familiarity with clinical dossiers, regulatory documentation, and Health Authority interactions
Demonstrated ability to integrate translational and biomarker data into clinical development decisions
Experience working in cross-functional, matrixed, and international teams
Familiarity with ICH-GCP, FDA and/or EMA expectations, and clinical trial regulations
Strong written and verbal communication skills in English
Ability to work independently, manage multiple priorities, and collaborate across time zones in an office-based environment.

工作职责

主要职责:

Lead assigned clinical studies and contribute to broader program strategy across the development continuum, from Phase 1 through Phase III, including support for registration-enabling activities, regulatory submissions, and Health Authority interactions.
Integrate clinical, translational, biomarker, and emerging data to support indication strategy, patient selection, dose strategy, and key development decisions.
Operate as a core member of cross-functional teams and the Global Project Team, partnering closely with Program Leadership and Management, Translational Medicine, Biostatistics, Clinical Pharmacology, Regulatory Affairs, Clinical Operations, Safety, and Medical Writing.
Support study design, dose strategy, patient selection, and indication prioritization
Integrate clinical, translational, and biomarker data into development decisions
Provide medical monitoring and clinical oversight for assigned studies
Review and interpret safety and efficacy data to support study decisions
Author and contribute to key clinical and regulatory documents, including protocols, investigator brochures, clinical study reports, briefing books, submission documents, and dossiers
Contribute to registration-enabling activities and regulatory submissions
Support interactions with Health Authorities and internal governance bodies
Drive execution of deliverables across global teams and timelines
Contribute to a high-performing, collaborative matrix environment.
关键能力:
Strong clinical judgment in oncology
Scientific and analytical rigor
Ability to translate complex clinical, translational, and biomarker findings into development strategy
Effective cross-functional collaboration; team player mentality
Clear and concise communication
Ownership, accountability, and execution focus
Comfort working in a fast-paced, global matrix organization

优先资格

优先资质要求:

Experience in targeted therapies, ADCs, immuno-oncology, and/or hematology/hematologic oncology
Experience across early and late clinical development
Experience contributing to study designs that support potential registration pathways
Experience with precision medicine, and/or biomarker-driven development
Strong project leadership skills with a track record of driving timelines and decision points
Board certification in Medical Oncology/Hematology or relevant subspecialty.

AI 洞察

优缺点分析

优点

  • The role offers ownership of global oncology development programs across early and late stages, which can build deep end-to-end drug development experience.
  • Exposure to targeted therapies, ADCs, immuno-oncology, biomarkers, and registration activities keeps the work scientifically rich and strategically relevant.
  • Collaboration with global cross-functional teams provides broad visibility across clinical, regulatory, safety, biostatistics, and translational functions.
  • The position is linked to patient-focused healthcare innovation and potential therapies in a serious disease area.
  • The global matrix environment requires influencing without direct authority and coordinating across time zones and multiple functions.
  • Registration-enabling work and regulatory interactions demand high accuracy, strong documentation discipline, and comfort with complex decision-making.
  • The role requires balancing day-to-day study oversight with broader program strategy and multiple priorities.
  • This role suits physicians with oncology expertise and pharmaceutical clinical development experience who want to lead global studies and influence registration strategy. It is especially fit for candidates comfortable with matrix collaboration, regulatory documentation, and data-driven development decisions.

缺点 / 挑战

暂无明显挑战项

角色解读

  • Grow into senior global clinical development leadership roles overseeing broader oncology programs or multiple assets.
  • Move toward strategic roles in regulatory affairs, translational medicine, medical affairs, or portfolio leadership.
  • Build a path toward senior medical director, clinical development head, or therapeutic area leadership positions.
  • Lead oncology clinical studies from Phase 1 through Phase III, providing medical and scientific direction across the development lifecycle.
  • Integrate clinical, translational, biomarker, safety, and efficacy data to shape indication strategy, dose strategy, and patient selection.
  • Author or contribute to protocols, investigator brochures, clinical study reports, briefing books, submission documents, and dossiers.
  • Partner with global cross-functional teams and support regulatory submissions and Health Authority interactions.
  • Strong oncology clinical judgment and expertise in clinical drug development, ideally across solid tumors, hematologic oncology, ADCs, targeted therapies, or immuno-oncology.
  • Ability to interpret translational and biomarker data and convert complex findings into development decisions.
  • Familiarity with ICH-GCP, FDA and/or EMA expectations, clinical trial regulations, dossiers, and registration-enabling activities.
  • Excellent English communication, project leadership, and collaboration skills in a global matrix environment.

申请策略

  • Make it explicit that you are eligible to work in the US, since the role does not offer work authorization sponsorship.
  • Tailor your application to show both medical leadership and operational execution in global matrix teams.
  • Highlight direct experience supporting or leading Phase 1 to Phase III oncology clinical studies, including specific assets and indications.
  • Show concrete contributions to clinical development strategy, study design, dose strategy, patient selection, and indication prioritization.
  • Emphasize regulatory submission experience, Health Authority interactions, dossiers, briefing books, protocols, and clinical study reports.
  • Demonstrate cross-functional leadership across translational medicine, biostatistics, clinical pharmacology, regulatory, safety, operations, and medical writing.
  • Strengthen knowledge of ADCs, targeted therapies, immuno-oncology, hematologic oncology, and biomarker-driven precision medicine development.
  • Deepen familiarity with FDA and EMA expectations, ICH-GCP, registration pathways, and clinical dossier standards.

面试指南

  • Use a structured case format: context, your medical role, data considered, stakeholders involved, decision made, and outcome.
  • For strategy questions, explain how you integrate efficacy, safety, translational data, biomarker evidence, regulatory expectations, and patient need.
  • For collaboration questions, emphasize ownership, clear communication, governance discipline, and ability to drive decisions in a matrix organization.
  • How have you led or supported oncology clinical studies across Phase 1 through Phase III?
  • Describe a time you used translational or biomarker data to influence a clinical development decision.
  • What experience do you have with regulatory submissions, registration-enabling activities, or Health Authority interactions?
  • How do you manage competing priorities and align global cross-functional teams around development timelines?
  • How would you approach dose strategy and patient selection for a targeted therapy or ADC program?

职位点评

薪资福利82
成长发展86
工作生活62
使命价值90

薪资福利

82较高

The JD discloses a base pay range and mentions eligibility for performance-based bonuses, health insurance, paid time off, and retirement contributions. Compensation signals are strong for a senior medical development role, though bonus eligibility is not guaranteed.

薪资信号偏高 (1.4–21.8万/月)
福利待遇health insurance、paid time off (PTO)、retirement contributions、performance-based bonuses

成长发展

86较高

The role offers broad development exposure across Phase 1 to Phase III programs, registration activities, biomarkers, translational medicine, and global cross-functional leadership. The JD also mentions personal development and career advancement opportunities, but does not describe a formal promotion path.

技术前沿前沿/新兴技术
技术栈targeted therapies、antibody-drug conjugates (ADCs)、immuno-oncology、biomarker、translational medicine、precision medicine
成长机会personal development、career advancement
业务类型ambiguous

工作生活

62中等

The JD explicitly states an onsite hybrid model and travel below 20%, which indicates some flexibility but also requires office presence. No details are provided about specific remote days, schedule flexibility, or work-life balance practices.

工作模式混合式弹性办公
办公地点未明确
加班情况未提及(无法判断)
工作生活平衡flexible working culture

使命价值

90较高

The JD strongly emphasizes patient purpose, improving and prolonging lives, innovation in oncology, and contributing to therapies that can affect patients at different life stages. The mission and scientific impact signals are central to the role.

行业发展高速增长赛道
社会影响正向社会影响力较高
使命信号enrich people’s lives、caring for our rich mix of people, customers, patients, and planet、United As One for Patients、help create, improve and prolong lives、help patients at every stage of life、Sparking Discovery and Elevating Humanity
创新程度积极采用新技术
Watch Jobs